The MTT assay is based on the conversion of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide into purple formazan crystals by LIVINGcells, which determines the mitochondrial activity of these cells. Viable cells contain NADPH-dependent oxidoreductase enzymes which reduce MTT to formazan.1The insoluble formazan crystals are dissolved using a solubilization solution (e.g. acidified isopropanol, DMSO) and the resultant coloured solution is quantified by measuring the absorbance at 500-600nm using a multi-plate spectrophotometer. The darker the solution, the greater the number of viable, metabolically active cells2.Since for most cell populations, the total mitochondrialactivity would be proportional to the number of viablecells, this assay is widely used in characterizingthe cytotoxiceffects of drugs or nanoparticleformulationson immortalized cell line or primary cell cultures.